HUP0002346A1 - Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény - Google Patents
Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítményInfo
- Publication number
- HUP0002346A1 HUP0002346A1 HU0002346A HUP0002346A HUP0002346A1 HU P0002346 A1 HUP0002346 A1 HU P0002346A1 HU 0002346 A HU0002346 A HU 0002346A HU P0002346 A HUP0002346 A HU P0002346A HU P0002346 A1 HUP0002346 A1 HU P0002346A1
- Authority
- HU
- Hungary
- Prior art keywords
- mammals
- treatment
- pharmaceutical composition
- mental illness
- alpha
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title abstract 2
- 208000020016 psychiatric disease Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000012563 Alpha 2C adrenoceptor Human genes 0.000 abstract 1
- 108050002082 Alpha 2C adrenoceptor Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 abstract 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 abstract 1
- 229960003529 diazepam Drugs 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A találmány tárgya gyógyszerkészítmény, amely emlősöknél stressz általkiváltott elmezavar kezelésére alkalmas és hatóanyagként az alfa-2C-adrenoceptorra szelektív alfa-2-adrenoceptor antagonistát (pl.diazepam) tartalmaz. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/854,730 US5902807A (en) | 1997-05-12 | 1997-05-12 | Method for the treatment of mental illness in mammals and a composition therefor |
PCT/FI1998/000398 WO1998051310A1 (en) | 1997-05-12 | 1998-05-11 | A method for the treatment of mental illness in mammals and a composition therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0002346A1 true HUP0002346A1 (hu) | 2001-05-28 |
HUP0002346A3 HUP0002346A3 (en) | 2001-09-28 |
Family
ID=25319419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0002346A HUP0002346A3 (en) | 1997-05-12 | 1998-05-11 | Pharmaceutical composition for the treatment of mental illness in mammals |
Country Status (12)
Country | Link |
---|---|
US (1) | US5902807A (hu) |
EP (1) | EP1003518A1 (hu) |
JP (1) | JP2001524979A (hu) |
AU (1) | AU744096B2 (hu) |
BR (1) | BR9808784A (hu) |
CA (1) | CA2288650C (hu) |
EE (1) | EE03667B1 (hu) |
HU (1) | HUP0002346A3 (hu) |
NO (1) | NO995469L (hu) |
PL (1) | PL336771A1 (hu) |
SK (1) | SK154199A3 (hu) |
WO (1) | WO1998051310A1 (hu) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6593324B2 (en) * | 2000-03-01 | 2003-07-15 | Orion Corporation | Dervatives of quinoline as alpha-2 antagonists |
JP2003048831A (ja) * | 2001-08-02 | 2003-02-21 | Suntory Ltd | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
DE10138275A1 (de) * | 2001-08-10 | 2003-02-27 | Boehringer Ingelheim Pharma | Verbindungen zur Beseitigung der Anhedonie |
DE60316672T2 (de) * | 2002-04-03 | 2008-07-17 | Orion Corp. | Polycyclische verbindungen als potente alpha2-adrenoceptor antagonisten |
WO2003082825A1 (en) * | 2002-04-03 | 2003-10-09 | Orion Corporation | Use of an alfa2-adrenoreceptor antagonist for cns-related diseases |
EP1542670B2 (en) * | 2002-09-24 | 2023-07-05 | Suntory Holdings Limited | Composition containing arachidonic acid alone or in combination with docosahexaenoic acid for enhancing cognitive abilities in adults |
JP4522075B2 (ja) * | 2003-10-29 | 2010-08-11 | サントリーホールディングス株式会社 | 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
JP4993852B2 (ja) | 2004-09-17 | 2012-08-08 | サントリーホールディングス株式会社 | ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
JP2006083136A (ja) * | 2004-09-17 | 2006-03-30 | Suntory Ltd | ストレスに起因する脳機能の低下およびそれに伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
JP5697293B2 (ja) * | 2005-06-30 | 2015-04-08 | サントリーホールディングス株式会社 | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 |
JP5967855B2 (ja) * | 2005-06-30 | 2016-08-10 | サントリーホールディングス株式会社 | 日中活動量の低下および/又はうつ症状の改善作用を有する組成物 |
JPWO2008081989A1 (ja) * | 2006-12-28 | 2010-04-30 | サントリーホールディングス株式会社 | 神経再生剤 |
TWI457122B (zh) | 2007-07-20 | 2014-10-21 | Orion Corp | 作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3-二氫苯並[1,4]戴奧辛-2-基甲基衍生物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3274579B2 (ja) * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | 脳血管障害に伴う精神症候治療剤 |
-
1997
- 1997-05-12 US US08/854,730 patent/US5902807A/en not_active Expired - Fee Related
-
1998
- 1998-05-11 EP EP98921508A patent/EP1003518A1/en not_active Withdrawn
- 1998-05-11 WO PCT/FI1998/000398 patent/WO1998051310A1/en active IP Right Grant
- 1998-05-11 PL PL98336771A patent/PL336771A1/xx unknown
- 1998-05-11 JP JP54883698A patent/JP2001524979A/ja active Pending
- 1998-05-11 AU AU74334/98A patent/AU744096B2/en not_active Ceased
- 1998-05-11 CA CA002288650A patent/CA2288650C/en not_active Expired - Fee Related
- 1998-05-11 EE EEP199900561A patent/EE03667B1/xx not_active IP Right Cessation
- 1998-05-11 BR BR9808784-3A patent/BR9808784A/pt not_active IP Right Cessation
- 1998-05-11 SK SK1541-99A patent/SK154199A3/sk unknown
- 1998-05-11 HU HU0002346A patent/HUP0002346A3/hu unknown
-
1999
- 1999-11-08 NO NO995469A patent/NO995469L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2288650C (en) | 2007-09-25 |
NO995469D0 (no) | 1999-11-08 |
SK154199A3 (en) | 2001-01-18 |
CA2288650A1 (en) | 1998-11-19 |
EP1003518A1 (en) | 2000-05-31 |
WO1998051310A1 (en) | 1998-11-19 |
EE03667B1 (et) | 2002-04-15 |
JP2001524979A (ja) | 2001-12-04 |
US5902807A (en) | 1999-05-11 |
NO995469L (no) | 1999-11-08 |
EE9900561A (et) | 2000-06-15 |
BR9808784A (pt) | 2000-08-01 |
AU744096B2 (en) | 2002-02-14 |
PL336771A1 (en) | 2000-07-17 |
AU7433498A (en) | 1998-12-08 |
HUP0002346A3 (en) | 2001-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS5198A (is) | Ný efnasambönd | |
HUP0104709A2 (hu) | Eritropoietin vagy eritropoietrinszármazékok alkalmazása agyi iszkémiák kezelésére használható gyógyszer előállítására | |
HUP0104318A2 (hu) | cGMP PDE-5 inhibitort tartalmazó szabályzottan hatóanyagot felszabadító gyógyászati készítmények | |
HUP0201877A2 (hu) | Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák | |
HUP0203586A2 (hu) | Szerotonin újrafelvétel inhibitorának, valamint 5-ht2c antagonistának, inverz agonistának vagy részleges agonistának a kombinációja | |
NO996433D0 (no) | Nye formuleringer av legemidler, fremgangsmåter for fremstilling derav og fremgangsmåter for anvendelse derav | |
EE9700328A (et) | Tahke oraalne preparaat, mis sisaldab toimeainena olansapiini, selle valmistamismeetod ja kasutamine | |
MXPA04003668A (es) | Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos. | |
HUP0101411A2 (hu) | 2-es típusú angiotenzin II receptor agonistákat tartalmazó gyógyszerkészítmények és ezek alkalmazása | |
HUP0002346A1 (hu) | Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény | |
HUP0102365A2 (hu) | Lipofil glükokortikoszteroidot és csak egy felületaktív anyagot tartalmazó micellákból álló gyógyszerkészítmények, valamint eljárás előállításukra | |
HUP0301349A2 (hu) | IL-11-tartalmú készítmények | |
AU2001266152A1 (en) | Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them | |
HUP0104647A2 (hu) | Hatóanyagként tilidin-mezilátot tartalmazó, szabályozott hatóanyag-leadású gyógyszerkészítmény | |
EE03663B1 (et) | Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine | |
DE60202590D1 (de) | 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen | |
BG108452A (en) | Tablet comprising cetirizine and pseudoephedrine | |
HUP0100611A2 (hu) | Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére | |
PL360465A1 (en) | Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them | |
ES2089286T3 (es) | Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos. | |
WO1999020291A3 (en) | Pharmaceutical grade ginkgo biloba | |
HUP0500078A2 (hu) | PDE inhibitort és leukotrién antagonistát tartalmazó kombinált gyógyszerkészítmény | |
ATE226065T1 (de) | Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung | |
HK1065305A1 (en) | Substituted 4-aminocyclohexanol derivatives | |
EP1273301A3 (en) | Pharmaceutical preparations based on active ingredients susceptible to illict administration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |